Ask the expert: economists
Dr. Scott Grosse
Scott Grosse trained in population and development economics at the University of Michigan. Since 1996 he has been employed at the Centers for Disease Control and Prevention (CDC) in Atlanta, where he currently serves as Associate Director for Health Services Research and Evaluation in the Division of Blood Disorders in the National Center on Birth Defects and Developmental Disabilities, and works on disorders such as haemoglobinopathies, hemophilia, hereditary hemochromatosis, hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu) and thrombophilia. He has published on the clinical and personal utility of genetic tests, including for specific conditions, e.g., Lynch syndrome. He has a particular interest in the impact and cost-effectiveness of newborn screening for disorders such as PKU, congenital hypothyroidism, congenital adrenal hyperplasia, cystic fibrosis, and sickle cell disease.